Cargando…
血清细胞角蛋白19在预测进展期非小细胞肺癌患者化疗疗效及预后中的临床意义
BACKGROUND AND OBJECTIVE: RECIST (Response Evaluation Criteria in Solid Tumors) criteria could not be used to detect viable tumor tissue and is not an accurate tool for evaluation of objective response (OR) in non-small cell lung cancer (NSCLC) patients without measurable lesions. The aim of this st...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000587/ https://www.ncbi.nlm.nih.gov/pubmed/20959068 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.10.05 |
Ejemplares similares
-
治疗前后NLR和PLR对进展期非小细胞肺癌一线化疗疗效及预后的预测价值
Publicado: (2018) -
检测Ⅰ期肺癌患者血清C反应蛋白的预后意义
Publicado: (2011) -
血清细胞角蛋白19片段与胸腺肿瘤临床病理特征和预后的相关性研究
Publicado: (2018) -
局部放疗联合化疗在广泛期小细胞肺癌患者中的作用
Publicado: (2015) -
BRCA1:一种新的非小细胞肺癌放化疗疗效的预测基因
Publicado: (2012)